Legal Representation
Attorney
Nicole Kinsley, Esq.
USPTO Deadlines
Next Deadline
187 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 16, 2026
Extension Available
Until July 16, 2025
Application History
31 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 30, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 30, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Apr 29, 2025 | EXT2 | S | SOU EXTENSION 2 FILED |
| Apr 29, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 6, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 6, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 6, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jul 16, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 21, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 1, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 17, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 16, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Apr 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 20, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Nov 20, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Oct 17, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Oct 17, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 17, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Oct 16, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Sep 26, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Sep 13, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 13, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 30, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Jun 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jun 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 12, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 10, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
House mark for pharmaceutical preparations for human use for the treatment of microvascular diseases and eye diseases
Class 042
Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields
Classification
International Classes
005
042
USPTO Documents
Loading USPTO documents...